Single Arm Phase II Study of Ipilimumab and Nivolumab as

Project: Research project

Project Details

Description

Single Arm Phase II Study of Ipilimumab and Nivolumab as Adjuvant Therapy for Resected Mucosal Melanoma (SALVO study)
StatusActive
Effective start/end date12/1/171/31/21

Funding

  • BIG TEN CANCER RESEARCH CONSORTIUM

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.